Saurabh Saha, Ph.D. - Publications

Affiliations: 
2004 Johns Hopkins University, Baltimore, MD 
Area:
Oncology

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Szabo PM, Vajdi A, Kumar N, Tolstorukov MY, Chen BJ, Edwards R, Ligon KL, Chasalow SD, Chow KH, Shetty A, Bolisetty M, Holloway JL, Golhar R, Kidd BA, Hull PA, ... ... Saha S, et al. Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment. Scientific Reports. 13: 3051. PMID 36810872 DOI: 10.1038/s41598-023-28480-9  0.313
2018 Szot C, Saha S, Zhang XM, Zhu Z, Hilton MB, Morris K, Seaman S, Dunleavey JM, Hsu KS, Yu GJ, Morris H, Swing DA, Haines DC, Wang Y, Hwang J, et al. Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release. The Journal of Clinical Investigation. PMID 29863500 DOI: 10.1172/Jci120481  0.329
2018 DeClue AE, Axiak-Bechtel SM, Zhang Y, Saha S, Zhang L, Tung DD, Bryan JN. Identification of immunologic and clinical characteristics that predict inflammatory response to C. Novyi-NT bacteriolytic immunotherapy. Bmc Veterinary Research. 14: 119. PMID 29606140 DOI: 10.1186/S12917-018-1424-1  0.321
2017 Germann UA, Furey BF, Markland W, Hoover RR, Aronov AM, Roix JJ, Hale M, Boucher DM, Sorrell DA, Martinez-Botella G, Fitzgibbon M, Shapiro P, Wick MJ, Samadani R, Meshaw K, ... ... Saha S, et al. Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (ulixertinib). Molecular Cancer Therapeutics. PMID 28939558 DOI: 10.1158/1535-7163.Mct-17-0456  0.33
2017 Seaman S, Zhu Z, Saha S, Zhang XM, Yang MY, Hilton MB, Morris K, Szot C, Morris H, Swing DA, Tessarollo L, Smith SW, Degrado S, Borkin D, Jain N, et al. Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature. Cancer Cell. 31: 501-515.e8. PMID 28399408 DOI: 10.1016/J.Ccell.2017.03.005  0.33
2016 Zhang XM, Zhang HH, McLeroth P, Berkowitz RD, Mont MA, Stabin MG, Siegel BA, Alavi A, Barnett TM, Gelb J, Petit C, Spaltro J, Cho SY, Pomper MG, Conklin JJ, ... ... Saha S, et al. [(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection. Nuclear Medicine and Biology. 43: 273-9. PMID 27150029 DOI: 10.1016/J.Nucmedbio.2016.01.004  0.439
2015 Germann U, Furey B, Roix J, Markland W, Hoover R, Aronov A, Hale M, Chen G, Martinez-Botella G, Alargova R, Fan B, Sorrell D, Meshaw K, Shapiro P, Wick MJ, ... ... Saha S, et al. Abstract 4693: The selective ERK inhibitor BVD-523 is active in models of MAPK pathway-dependent cancers, including those with intrinsic and acquired drug resistance Cancer Research. 75: 4693-4693. DOI: 10.1158/1538-7445.Am2015-4693  0.339
2014 Roberts NJ, Zhang L, Janku F, Collins A, Bai RY, Staedtke V, Rusk AW, Tung D, Miller M, Roix J, Khanna KV, Murthy R, Benjamin RS, Helgason T, Szvalb AD, ... ... Saha S, et al. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Science Translational Medicine. 6: 249ra111. PMID 25122639 DOI: 10.1126/Scitranslmed.3008982  0.572
2014 Roix JJ, Harrison SD, Rainbolt EA, Meshaw KR, McMurry AS, Cheung P, Saha S. Systematic repurposing screening in xenograft models identifies approved drugs with novel anti-cancer activity. Plos One. 9: e101708. PMID 25093583 DOI: 10.1371/Journal.Pone.0101708  0.307
2014 Tung D, DeCrescenzo G, Welsch D, Cheung PH, Bettegowda C, Saha S. Evaluation of 1-(2-deoxy-2-fluoro-1-D-arabinofuranosyl)-5-iodouracil (FIAU) as an ex vivo bacterial detection agent. World Journal of Microbiology & Biotechnology. 30: 3003-10. PMID 25085723 DOI: 10.1007/S11274-014-1709-X  0.461
2007 Peters BA, St Croix B, Sjöblom T, Cummins JM, Silliman N, Ptak J, Saha S, Kinzler KW, Hatzis C, Velculescu VE. Large-scale identification of novel transcripts in the human genome. Genome Research. 17: 287-92. PMID 17267814 DOI: 10.1101/Gr.5486607  0.623
2005 Polato F, Codegoni A, Fruscio R, Perego P, Mangioni C, Saha S, Bardelli A, Broggini M. PRL-3 phosphatase is implicated in ovarian cancer growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6835-9. PMID 16203771 DOI: 10.1158/1078-0432.Ccr-04-2357  0.353
2005 Lengauer C, Diaz LA, Saha S. Cancer drug discovery through collaboration. Nature Reviews. Drug Discovery. 4: 375-80. PMID 15864266 DOI: 10.1038/Nrd1722  0.318
2004 Parker BS, Argani P, Cook BP, Liangfeng H, Chartrand SD, Zhang M, Saha S, Bardelli A, Jiang Y, St Martin TB, Nacht M, Teicher BA, Klinger KW, Sukumar S, Madden SL. Alterations in vascular gene expression in invasive breast carcinoma. Cancer Research. 64: 7857-66. PMID 15520192 DOI: 10.1158/0008-5472.Can-04-1976  0.362
2004 Wang TL, Diaz LA, Romans K, Bardelli A, Saha S, Galizia G, Choti M, Donehower R, Parmigiani G, Shih IM, Iacobuzio-Donahue C, Kinzler KW, Vogelstein B, Lengauer C, Velculescu VE. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients Proceedings of the National Academy of Sciences of the United States of America. 101: 3089-3094. PMID 14970324 DOI: 10.1073/Pnas.0308716101  0.502
2004 Parker BS, Argani P, Cook BP, Liangfeng H, Chartrand SD, Zhang M, Saha S, Bardelli A, Jiang Y, Martin TBS, Nacht M, Teicher BA, Klinger KW, Sukumar S, Madden SL. Erratum: Alterations in vascular gene expression in invasive breast carcinoma (Cancer Research (November 1, 2004) 64, 1 (7857-7866)) Cancer Research. 64. DOI: 10.1158/0008-5472.Can-64-23-Cor  0.317
2003 Bardelli A, Saha S, Sager JA, Romans KE, Xin B, Markowitz SD, Lengauer C, Velculescu VE, Kinzler KW, Vogelstein B. PRL-3 Expression in Metastatic Cancers Clinical Cancer Research. 9: 5607-5615. PMID 14654542  0.498
2003 Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, Saha S, Markowitz S, Willson JKV, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE. Mutational analysis of the tyrosine kinome in colorectal cancers Science. 300: 949. PMID 12738854 DOI: 10.1126/Science.1082596  0.51
2003 Gottsch JD, Seitzman GD, Margulies EH, Bowers AL, Michels AJ, Saha S, Jun AS, Stark WJ, Liu SH. Gene expression in donor corneal endothelium. Archives of Ophthalmology (Chicago, Ill. : 1960). 121: 252-8. PMID 12583793 DOI: 10.1001/Archopht.121.2.252  0.373
2003 Gottsch JD, Bowers AL, Margulies EH, Seitzman GD, Kim SW, Saha S, Jun AS, Stark WJ, Liu SH. Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy. Investigative Ophthalmology & Visual Science. 44: 594-9. PMID 12556388 DOI: 10.1167/Iovs.02-0300  0.375
2002 Saha S, Sparks AB, Rago C, Akmaev V, Wang CJ, Vogelstein B, Kinzler KW, Velculescu VE. Using the transcriptome to annotate the genome. Nature Biotechnology. 20: 508-12. PMID 11981567 DOI: 10.1038/Nbt0502-508  0.523
2001 Saha S, Bardelli A, Buckhaults P, Velculescu VE, Rago C, St Croix B, Romans KE, Choti MA, Lengauer C, Kinzler KW, Vogelstein B. A phosphatase associated with metastasis of colorectal cancer. Science (New York, N.Y.). 294: 1343-6. PMID 11598267 DOI: 10.1126/Science.1065817  0.544
2001 Buckhaults P, Rago C, St Croix B, Romans KE, Saha S, Zhang L, Vogelstein B, Kinzler KW. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Research. 61: 6996-7001. PMID 11585723  0.514
Show low-probability matches.